Licences and regulatory standing
DHA/DOH/MOH licences, clean inspection history and transferable facility approvals are the foundation of the multiple. Anything that delays a licence transfer delays — or reprices — the deal.
Valuation multiples · UAE
Healthcare services and clinics in the SME bracket transact around 5–7× EBITDA. Buyers pay for licensed capacity that generates earnings without depending on one clinician — and discount everything that doesn’t transfer.
The headline basis is EBITDA, normalised for owner-clinician compensation at market rates. If the owner is also the highest-billing practitioner, expect diligence to model the cost of replacing those hours — that adjustment alone can move a clinic from the top of the band to below it.
These are SME transaction bands from global deal data — open-source GCC/MENA SME comps are too thin to quote as a separate series, so treat the range as the starting grid, not a Gulf-specific promise. They are not public-market multiples: a quoted comparable carries a size and illiquidity discount of roughly 15–35% before it applies to a private SME. Size then moves you within the band — larger, cleaner businesses clear the top; smaller, owner-dependent ones price near the bottom.
DHA/DOH/MOH licences, clean inspection history and transferable facility approvals are the foundation of the multiple. Anything that delays a licence transfer delays — or reprices — the deal.
Revenue concentrated in one or two practitioners (especially a selling owner) is the sector’s classic key-person discount. Multi-practitioner coverage with documented referral flows holds the band.
A balanced insurance panel with current contracts and clean receivables supports the top of the band. Heavy dependence on one payor, or ageing insurance receivables, gets priced as risk.
Buyers model capacity: rooms, chairs, scanner hours. Demonstrated utilisation headroom on a long, assignable lease is upside they will pay for; a short lease in a fitted-out facility is risk they will not.
Multiplying earnings by a band produces an enterprise value (EV). What a sale actually puts in your pocket is equity value: EV minus debt and debt-like items (shareholder loans, end-of-service liabilities, overdue payables), plus genuinely surplus cash, adjusted for working capital. Two businesses with identical EV can hand their owners very different proceeds once that bridge is built — which is why our calculator returns both numbers, not just the headline.
SME healthcare services cluster around 5–7× normalised EBITDA (global SME bands — there is no quotable open UAE clinic comp series). Licences in good standing, multi-clinician revenue and a balanced payor mix put you at the top of that range; key-person dependence pulls you below it.
Diligence will price the cost of replacing your clinical hours and your patient relationships. Building a second revenue-generating clinician and documented handover plan 12–18 months before a sale is one of the highest-ROI moves in this sector.
A licence has option value, but earnings carry the multiple. A licensed-but-underutilised facility is typically priced on demonstrated EBITDA plus a negotiated premium for capacity — not on what the licence could theoretically produce.
The free calculator applies these same bands to your numbers — the earnings basis chosen by company size, the position inside the band set by quality — and returns an enterprise-value range with the EV→equity bridge, not a single flattering point.
Indicative only. This figure is an automated, indicative estimate generated from the limited information you provided and from general market data for comparable companies. It is not a valuation, an appraisal, a fairness opinion, or financial, investment, legal, tax, or accounting advice, and it is not an offer or a solicitation to buy or sell any business or security. Every business is different; an indicative range produced from sector averages can differ materially from the price an actual buyer or investor would pay.
No reliance; subject to diligence. Fiducia Adamantina gives no representation or warranty as to the accuracy or completeness of this estimate and accepts no liability for any decision taken in reliance on it. Any real valuation depends on full financial and legal due diligence, the specific facts of your business, and prevailing market conditions at the time of a transaction. You should not act, or refrain from acting, on the basis of this output alone. For a defensible assessment, speak to us directly.
We use analytics cookies to understand how the site is used and improve it. They load only if you accept. Privacy Policy